[PREVENTIVE ACTION OF NOR-ANDROSTENOLONE PHENYLPROPIONATE (N.A.P.P.) IN EXPERIMENTAL TUMORIZATION. (NEW SERIES)].
D045930:Anabolic Agents; D000818:Animals; D002128:Calcium Metabolism Disorders; D003687:Dehydroepiandrosterone; D008660:Metabolism; D051379:Mice; D009369:Neoplasms; D009374:Neoplasms, Experimental; D010600:Pharmacology; D010666:Phenylpropionates; D010758:Phosphorus / Q000378:metabolism*; D011188:Potassium; D012106:Research; D013256:Steroids; D045165:Testosterone Congeners
D045930:Anabolic Agents; D010666:Phenylpropionates; D013256:Steroids; D045165:Testosterone Congeners; D010758:Phosphorus; D003687:Dehydroepiandrosterone; D011188:Potassium
ANABOLIC STEROIDS; CALCIUM METABOLISM DISORDERS; EXPERIMENTAL LAB STUDY; METABOLISM; MICE; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; PHOSPHORUS METABOLISM; POTASSIUM
ACTION PR'EVENTIVE DU PH'ENYLPROPIONATE DE NOR-ANDROST'ENOLONE (P.P.N.A.) DANS LA TUMORISATION EXP'ERIMENTALE.